.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
McKinsey
Dow
Farmers Insurance
Deloitte
Johnson and Johnson
Citi
Boehringer Ingelheim
AstraZeneca
Queensland Health

Generated: June 26, 2017

DrugPatentWatch Database Preview

Ipratropium bromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for ipratropium bromide and what is the scope of ipratropium bromide freedom to operate?

Ipratropium bromide
is the generic ingredient in three branded drugs marketed by Sun Pharma Global, Bausch And Lomb, Pharmascience Inc, Actavis Mid Atlantic, Teva Pharms Usa, Boehringer Ingelheim, Bausch And Lomb Inc, Apotex Inc, Aurobindo Pharma Ltd, Mylan Speciality Lp, Nephron, West-ward Pharms Int, Roxane, Landela Pharm, Watson Labs, and Ritedose Corp, and is included in twenty-six NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ipratropium bromide has fifty-four patent family members in thirty-seven countries.

There are seven drug master file entries for ipratropium bromide. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: ipratropium bromide

Tradenames:3
Patents:4
Applicants:16
NDAs:26
Drug Master File Entries: see list7
Suppliers / Packagers: see list21
Bulk Api Vendors: see list60
Clinical Trials: see list304
Patent Applications: see list7,645
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ipratropium bromide at DailyMed

Pharmacology for Ingredient: ipratropium bromide

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ritedose Corp
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075693-001Jan 26, 2001ANRXNoYes► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
AEROSOL, METERED;INHALATION019085-001Dec 29, 1986DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb Inc
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075835-001Oct 15, 2001ANRXNoNo► Subscribe► Subscribe
Pharmascience Inc
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION075507-001Jan 19, 2001DISCNNoNo► Subscribe► Subscribe
Sun Pharma Global
IPRATROPIUM BROMIDE
ipratropium bromide
SOLUTION;INHALATION207903-001Jan 3, 2017ANRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 19954,385,048► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020394-001Oct 20, 19954,385,048► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 20045,766,573► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 20045,676,930► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 20045,695,743► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ipratropium bromide

Country Document Number Estimated Expiration
Czech Republic305422► Subscribe
Slovakia286477► Subscribe
Poland352052► Subscribe
Germany102007045438► Subscribe
Turkey200103410► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Federal Trade Commission
Dow
Accenture
Daiichi Sankyo
Citi
QuintilesIMS
Cerilliant
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot